Accuray and c-rad unveil automated breast cancer treatment package for the radixact® system at american society for radiation oncology (astro) annual meeting

Sunnyvale, calif. , oct. 13, 2022 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today the company, in partnership with c-rad ab (nasdaq stockholm: crad b), will showcase an important new option for improving the care of people diagnosed with breast cancer during the 2022 astro (american society for radiation oncology) annual meeting in san antonio, texas, october 23 – 26, 2022.
ARAY Ratings Summary
ARAY Quant Ranking